Moreover, they illuminate Nox1 and TSP1-CD47 axis as attractive therapeutic targets for the treatment of non-healing diabetic wounds and various cardiovascular disorders associated with endothelial dysfunction and reduced angiogenic activity. This evidence concerns the gene NOX1 and endothelial dysfunction.